As of June 15, 2026, Next Meats trades at $0.01 with a market capitalization of $4.46M. The company operates as a publicly traded OTC equity with a narrowly diversified portfolio focused on alternative protein. As of January 31, 2024, Next Meats has a trailing 12-month revenue of $1.05M, indicating early-stage commercialization and minimal revenue traction.
Cyborg Score Rationale
Next Meats faces fundamental execution challenges: micro-cap valuation ($4.46M), minimal revenue ($1.05M as of early 2024), extreme dilution (437.6M shares outstanding), and a questionable corporate structure with conflicting registrations describing the entity as both an operating plant-based meat company and a shell company. The $0.01 stock price and lack of consistent financial reporting limit near-term credibility.
Top Insights
Regulatory/corporate structure discrepancy: SEC filings describe Next Meats as a shell company with no operations, conflicting with public marketing as an active plant-based meat manufacturer
Severe market capitalization decline: Trading at $0.01 (June 2026) reflects multi-year value deterioration from peak $0.09 in prior 12 months
Minimal commercial traction: $1.05M trailing revenue (Jan 2024) with 437.6M shares outstanding suggests failed scaling or stalled market penetration
Possible restructuring or liquidation risk: Extreme dilution combined with shell-company status raises questions about strategic direction and shareholder protection